Correlation Between Mineralys Therapeutics, and Genenta Science

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Genenta Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Genenta Science into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Genenta Science SpA, you can compare the effects of market volatilities on Mineralys Therapeutics, and Genenta Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Genenta Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Genenta Science.

Diversification Opportunities for Mineralys Therapeutics, and Genenta Science

0.67

Correlation Coefficient

Mineralys Therapeutics,  Genenta Science

Poor diversification

The 3 months correlation between Mineralys and Genenta is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Genenta Science SpA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genenta Science SpA and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Genenta Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genenta Science SpA has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Genenta Science go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Genenta Science

Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 2.4 times less return on investment than Genenta Science. But when comparing it to its historical volatility, Mineralys Therapeutics, Common is 1.62 times less risky than Genenta Science. It trades about 0.06 of its potential returns per unit of risk. Genenta Science SpA is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  400.00  in Genenta Science SpA on September 12, 2024 and sell it today you would earn a total of  115.00  from holding Genenta Science SpA or generate 28.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Genenta Science SpA

Mineralys Therapeutics,

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Mineralys Therapeutics, unveiled solid returns over the last few months and may actually be approaching a breakup point.

Genenta Science SpA

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Genenta Science SpA are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Genenta Science sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Mineralys Therapeutics, and Genenta Science

The main advantage of trading using opposite Mineralys Therapeutics, and Genenta Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Genenta Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genenta Science will offset losses from the drop in Genenta Science's long position.

The idea behind Mineralys Therapeutics, Common and Genenta Science SpA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.